Actively Recruiting
The Improve Acute Reperfusion Treatment Quality for Ischemic Stroke Through Spatiotemporal Computing in China
Led by Beijing Tiantan Hospital · Updated on 2025-06-11
1280
Participants Needed
1
Research Sites
78 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study intends to construct the goal-oriented integrated intervention model for AIS in-hospital procedure through the spatiotemporal positioning and the P-D-C-A cycle for continuous improvement (FAST model). Then a multicenter, evaluator-blind, cluster-randomized controlled study aims to verify the validity and safety of this FAST model.
CONDITIONS
Official Title
The Improve Acute Reperfusion Treatment Quality for Ischemic Stroke Through Spatiotemporal Computing in China
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Hospitals must be secondary or tertiary public hospitals with emergency departments treating acute ischemic stroke patients.
- Hospitals must admit at least 50 patients with acute ischemic stroke within 4.5 hours of onset each month.
- Hospitals must have the capacity to provide intravenous thrombolytic therapy and/or endovascular treatment.
- Hospitals must voluntarily participate and cooperate with installation of Bluetooth positioning devices and emergency procedure improvements.
- Hospitals must have good cooperation among Neurology, Emergency, Interventional, Neurosurgery, Laboratory, and Radiology departments.
- Hospitals must be able to establish or participate in a patient information database and assign personnel to collect case information.
- Patients must be 18 years or older with acute ischemic stroke diagnosed by CT or MRI.
- Patients must arrive at the hospital within 4.5 hours of symptom onset.
- Patients must sign informed consent and agree to follow-up for 3 months after stroke onset.
You will not qualify if you...
- Hospitals unable to cooperate or complete the research.
- Hospitals participating in other acute ischemic stroke medical quality improvement projects or related clinical trials.
- Patients who refuse to sign informed consent or to follow up for 3 months after stroke onset.
- Patients with mild non-disabling stroke symptoms (NIHSS ≤3) such as isolated facial paralysis, mild cortical blindness, mild hemianesthesia, or mild hemiataxia.
- Patients with a life expectancy of 3 months or less as judged by the investigator.
- Patients participating in any interventional study that may affect the outcome.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
WuQing People's Hospital
Tianjin, Tianjin Municipality, China, 301799
Actively Recruiting
Research Team
Z
Zixiao Li, MD
CONTACT
Y
Yongjun Wang, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here